These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 25982453)
1. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study. Angelin M; Forsell J; Granlund M; Evengård B; Palmgren H; Johansson A Travel Med Infect Dis; 2015; 13(3):223-9. PubMed ID: 25982453 [TBL] [Abstract][Full Text] [Related]
3. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. Ostholm-Balkhed A; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A; J Antimicrob Chemother; 2013 Sep; 68(9):2144-53. PubMed ID: 23674762 [TBL] [Abstract][Full Text] [Related]
4. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265 [TBL] [Abstract][Full Text] [Related]
5. Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study. ÖstholmBalkhed Å; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A; PLoS One; 2018; 13(10):e0205504. PubMed ID: 30356258 [TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers. Mizuno Y; Miura Y; Yamaguchi T; Matsumoto T Travel Med Infect Dis; 2016; 14(6):561-567. PubMed ID: 27769900 [TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies. Lääveri T; Vlot JA; van Dam AP; Häkkinen HK; Sonder GJB; Visser LG; Kantele A BMC Infect Dis; 2018 Jul; 18(1):341. PubMed ID: 30037325 [TBL] [Abstract][Full Text] [Related]
8. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Arcilla MS; van Hattem JM; Haverkate MR; Bootsma MCJ; van Genderen PJJ; Goorhuis A; Grobusch MP; Lashof AMO; Molhoek N; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J Lancet Infect Dis; 2017 Jan; 17(1):78-85. PubMed ID: 27751772 [TBL] [Abstract][Full Text] [Related]
9. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study. Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840 [TBL] [Abstract][Full Text] [Related]
10. Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: A cohort study in a German travel clinic (2016-2017). Meurs L; Lempp FS; Lippmann N; Trawinski H; Rodloff AC; Eckardt M; Klingeberg A; Eckmanns T; Walter J; Lübbert C; Travel Med Infect Dis; 2020; 33():101521. PubMed ID: 31770602 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres. Bilavsky E; Temkin E; Lerman Y; Rabinovich A; Salomon J; Lawrence C; Rossini A; Salvia A; Samso JV; Fierro J; Paul M; Hart J; Gniadkowski M; Hochman M; Kazma M; Klein A; Adler A; Schwaber MJ; Carmeli Y; Clin Microbiol Infect; 2014 Nov; 20(11):O804-10. PubMed ID: 24674024 [TBL] [Abstract][Full Text] [Related]
12. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. Kuenzli E; Jaeger VK; Frei R; Neumayr A; DeCrom S; Haller S; Blum J; Widmer AF; Furrer H; Battegay M; Endimiani A; Hatz C BMC Infect Dis; 2014 Oct; 14():528. PubMed ID: 25270732 [TBL] [Abstract][Full Text] [Related]
13. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia. Barreto Miranda I; Ignatius R; Pfüller R; Friedrich-Jänicke B; Steiner F; Paland M; Dieckmann S; Schaufler K; Wieler LH; Guenther S; Mockenhaupt FP J Travel Med; 2016 Feb; 23(2):tav024. PubMed ID: 26858272 [TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study. Kantele A; Mero S; Kirveskari J; Lääveri T Travel Med Infect Dis; 2017; 16():23-30. PubMed ID: 28153711 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital. Jolivet S; Vaillant L; Poncin T; Lolom I; Gaudonnet Y; Rondinaud E; Bendjelloul G; Lomont A; Lucet JC; Armand-Lefèvre L Clin Microbiol Infect; 2018 Dec; 24(12):1311-1314. PubMed ID: 29549056 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for Extended-Spectrum Beta-Lactamase-producing- Enterobacteriaceae in French military and civilian travelers: A cross-sectional analysis. Flateau C; Duron-Martinaud S; Haus-Cheymol R; Bousquet A; Delaune D; Ficko C; Merens A; Rapp C Travel Med Infect Dis; 2018; 23():44-48. PubMed ID: 29604430 [TBL] [Abstract][Full Text] [Related]
17. Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: Systematic review and meta-analysis. Wuerz TC; Kassim SS; Atkins KE Travel Med Infect Dis; 2020; 37():101823. PubMed ID: 32755674 [TBL] [Abstract][Full Text] [Related]
18. Do probiotics prevent colonization with multi-resistant Enterobacteriaceae during travel? A randomized controlled trial. Dall LB; Lausch KR; Gedebjerg A; Fuursted K; Storgaard M; Larsen CS Travel Med Infect Dis; 2019; 27():81-86. PubMed ID: 30508633 [TBL] [Abstract][Full Text] [Related]
19. Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis. Karanika S; Karantanos T; Arvanitis M; Grigoras C; Mylonakis E Clin Infect Dis; 2016 Aug; 63(3):310-8. PubMed ID: 27143671 [TBL] [Abstract][Full Text] [Related]
20. Varying high levels of faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health. Sun Q; Tärnberg M; Zhao L; Stålsby Lundborg C; Song Y; Grape M; Nilsson M; Tomson G; Nilsson LE PLoS One; 2014; 9(11):e113121. PubMed ID: 25405340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]